LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 231 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,501,000 | -6.3% | 75,496 | 0.0% | 2.43% | +12.2% |
| Q2 2022 | $6,939,000 | -16.2% | 75,496 | +2.6% | 2.17% | -7.9% |
| Q1 2022 | $8,279,000 | -21.9% | 73,596 | +7.3% | 2.35% | -24.3% |
| Q4 2021 | $10,595,000 | +13.0% | 68,596 | +1.9% | 3.11% | +10.1% |
| Q3 2021 | $9,376,000 | +6.2% | 67,296 | 0.0% | 2.82% | +10.7% |
| Q2 2021 | $8,829,000 | -11.2% | 67,296 | +3.2% | 2.55% | -18.4% |
| Q1 2021 | $9,937,000 | +69.6% | 65,180 | +10.6% | 3.13% | +25.1% |
| Q4 2020 | $5,860,000 | – | 58,921 | – | 2.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |